ACM
VIR icon

Aquatic Capital Management’s Vir Biotechnology VIR Stock Holding History

Aquatic Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-75,301
Closed -$675K – 1770
2026
Q1 		$675K Buy
+75,301
New +$600K 0.02% 662
2024
Q3 		– Sell
-5,600
Closed -$49.8K – 1569
2024
Q2 		$49.8K Buy
5,600
+4,300
+331% +$41.2K ﹤0.01% 1015
2024
Q1 		$13.2K Sell
1,300
-1,800
-58% -$18.3K ﹤0.01% 1127
2023
Q4 		$31K Buy
+3,100
New +$28.3K ﹤0.01% 1180
2022
Q4 		– Sell
-18,600
Closed -$359K – 1862
2022
Q3 		$359K Buy
+18,600
New +$473K 0.04% 485
2022
Q2 		– Sell
-1,200
Closed -$31K – 1587
2022
Q1 		$31K Buy
+1,200
New +$35.6K 0.05% 387

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Aquatic Capital Management's VIR Position: Q2 2026 in Review

Aquatic Capital Management sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 75,301 shares — an estimated $675K sold.

Aquatic Capital Management first reported a position in VIR in Q1 2022 and held it in 6 quarters. The position peaked at $675K in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Aquatic Capital Management reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 75,301 Vir Biotechnology shares in Q2 2026, an estimated $675K.
  • Aquatic Capital Management first reported a position in Vir Biotechnology in Q1 2022 and held it in 6 quarters.
  • Aquatic Capital Management's Vir Biotechnology position peaked at $675K in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.